HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

HENGRUI PHARMA

44.760

-0.840-1.84%

Volume:909.13K

Turnover:40.88M

Market Cap:297.07B

PE:32.44

High:45.500

Open:45.500

Low:44.620

Close:45.600

52wk High:94.869

52wk Low:43.020

Shares:6.64B

HK Float Shares:258.00M

Volume Ratio:0.72

T/O Rate:0.35%

Dividend:0.23

Dividend Rate:0.52%

EPS(LYR):1.380

ROE:12.46%

ROA:7.02%

PB:3.94

PE(LYR):32.44

PS:8.11

Loading ...

Overview Company News Filings

Hengrui Pharma to Close H-Share Register Ahead of 24 September 2026 Extraordinary Meeting

Bulletin Express

HENGRUI PHARMA Advances Pipeline with SHR-1179 Injection Clinical Trial Approval

BlackRock's Long Position in H-Shares of Jiangsu Hengrui Pharmaceuticals Increases to 7.21% on SEP 2 from 5.92% - HKEX

THOMSON REUTERS

Hengrui Pharma Subsidiary Gains Clinical Trial Approval for Weight Management Drug Candidate

August Buyback Report: 277 A-Share Firms Spend Over 13 Billion Yuan, More Than Half Beat the Shanghai Composite, Gaozheng Explosive Surges 68% in a Month

Evaluating the Potential Value of Hengrui's HRS-9531 in an Intensifying GIP Competitive Landscape

Hengrui Pharmaceuticals Gets China Regulatory Acceptance for Atopic Dermatitis Drug Application

MT Newswires Live

Update: Hengrui Pharma Unit Secures China Nod For Diabetes Drug Application

MT Newswires Live

Hengrui Pharma's HRS-7535 Tablet Marketing Authorization Application Accepted by China's NMPA

Hengrui Pharma Has Not Yet Initiated Its A-Share Buyback Program as of End-August

Jiangsu Hengrui's Subsidiary Receives Regulatory Nod for Diabetes Drug Application

Movement Alert｜HENGRUI PHARMA Falls 3.05% in Regular Trading, Mid-Year Earnings Under Pressure Amid Broad Pharma Sector Weakness

Hengrui Pharma's Interim Report Falls Flat: Legacy Blockbusters Fade as Revenue Posts First Half-Year Decline in Four Years

Movement Alert｜HENGRUI PHARMA Rises 3.04% in Regular Trading, GIC Private Limited Consecutively Increases Stake to 17.19%

Singapore Sovereign Fund Boosts Stake in Chinese Drugmaker with HK$185 Million Share Purchase

JPMorgan Chase & Co.'S Short Position in H-Shares of Jiangsu Hengrui Pharmaceuticals Co., Ltd. Increases to 3.72% on August 21 from 2.57% - HKEX

THOMSON REUTERS

Singapore's GIC Boosts Stake in Hengrui Pharma With HK$185 Million Share Purchase

HENGRUI PHARMA: GIC Private Limited Acquires Shares, Long Position Rises to 15.7%

Chinese Drug Regulator Accepts Hengrui Pharma's Drug Marketing Application for HRG2010 Capsules

MT Newswires Live

HENGRUI PHARMA's HRG2010 Capsule Marketing Application Accepted by NMPA

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigerfiesta.com/stock/01276/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"01276","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"01276\",,,,,undefined,":{"symbol":"01276","market":"HK","secType":"STK","nameCN":"HENGRUI PHARMA","latestPrice":44.76,"timestamp":1789615163936,"preClose":45.6,"halted":0,"volume":909125,"delay":0,"changeRate":-0.018421052631579022,"floatShares":258000000,"shares":6637000000,"eps":1.3797230699228833,"marketStatus":"Trading","change":-0.84,"latestTime":"09-17 11:20:50","open":45.5,"high":45.5,"low":44.62,"amount":40878482,"amplitude":0.019298,"askPrice":44.76,"askSize":1800,"bidPrice":44.68,"bidSize":9400,"shortable":3,"etf":0,"ttmEps":1.3606524908801356,"tradingStatus":2,"nextMarketStatus":{"tag":"Noon Closed","tradingStatus":4,"beginTime":1789617600000},"marketStatusCode":2,"adr":0,"listingDate":1747929600000,"exchange":"SEHK","adjPreClose":45.6,"dividendRate":0.005213,"openAndCloseTimeList":[[1789608600000,1789617600000],[1789621200000,1789632000000]],"volumeRatio":0.724162,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"600276","market":"SH","secType":"STK","nameCN":"Jiangsu Hengrui Pharmaceuticals Co.,Ltd.","latestPrice":43.36,"timestamp":1789615248000,"preClose":43.52,"halted":0,"volume":20225100,"delay":0,"premium":"-11.71"}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"01276\",,,,,undefined,":{"symbol":"01276","floatShares":258000000,"roa":"7.02%","roe":"12.46%","lyrEps":1.379723,"volumeRatio":0.724162,"shares":6637000000,"dividePrice":0.233851,"high":45.5,"amplitude":0.019298,"preClose":45.6,"low":44.62,"week52Low":43.02,"pbRate":"3.94","psRate":"8.11","week52High":94.869,"institutionHeld":0,"latestPrice":44.76,"committee":0.678571,"eps":1.3797230699228833,"divideRate":0.005225,"volume":909125,"delay":0,"ttmEps":1.3606524908801356,"open":45.5,"prevYearClose":71.002,"prevWeekClose":43.76,"prevMonthClose":46.06,"prevQuarterClose":57.85,"fiveDayClose":43.96,"twentyDayClose":49.66,"sixtyDayClose":56.6},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/01276\",params:#limit:5,,,undefined,":[{"date":"2026-08-19","symbol":"01276","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1787103000000,"name":null,"time":"","dateTimestamp":1787068800000,"actualEps":null},{"date":"2026-04-29","symbol":"01276","amount":0.22828,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"HK","newRecordDate":"2026-04-30","defaultRemindTime":1777426200000,"name":"恒瑞医药","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-05-27","payableDate":"2026-04-30","currency":"HKD","dateTimestamp":1777392000000,"payDate":"2026-05-27"},{"date":"2026-04-22","symbol":"01276","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1776821400000,"name":null,"time":"","dateTimestamp":1776787200000,"actualEps":null},{"date":"2026-03-26","symbol":"01276","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1774488600000,"name":null,"time":"","dateTimestamp":1774454400000,"actualEps":null},{"date":"2025-10-28","symbol":"01276","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1761615000000,"name":null,"time":"","dateTimestamp":1761580800000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"01276\",market:\"HK\",,,undefined,":[{"executeDate":"2026-04-29","recordDate":"2026-04-30","paymentDate":"2026-05-27","value":0.22828,"currency":"HKD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"01276\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0.2727,"buy":0.5455,"hold":0.1818,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5455,"analysts":11,"updateTime":1786723200000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/01276\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"01276","date":"2026-09-16","current":32.896424,"percent":0.01227,"low":36.382401,"twenty":43.825898,"median":51.677932,"eighty":56.983927,"high":65.582363,"avg":51.073535,"sd":7.480955,"marketCap":335564360039.49},"quantilePoints":[{"date":"2025-05-23","current":52.570963,"twenty":52.783176,"median":53.101495,"eighty":53.419815,"marketCap":390693388207.53},{"date":"2025-05-30","current":53.015805,"twenty":51.822085,"median":52.540895,"eighty":52.926837,"marketCap":395731540422.24},{"date":"2025-06-06","current":52.120101,"twenty":52.130014,"median":52.555929,"eighty":53.075252,"marketCap":390038198012.59},{"date":"2025-06-13","current":52.209491,"twenty":52.177631,"median":52.691227,"eighty":53.357137,"marketCap":390861633032.23},{"date":"2025-06-20","current":50.172412,"twenty":51.591196,"median":52.469796,"eighty":53.075252,"marketCap":374874997562.85},{"date":"2025-06-27","current":50.314776,"twenty":50.363569,"median":52.169666,"eighty":53.013533,"marketCap":376991477472.78},{"date":"2025-07-04","current":51.666141,"twenty":50.343584,"median":52.120101,"eighty":53.004446,"marketCap":387134991658.26},{"date":"2025-07-11","current":55.507007,"twenty":50.44351,"median":52.13337,"eighty":53.090114,"marketCap":415495681161.23},{"date":"2025-07-18","current":57.272274,"twenty":50.582121,"median":52.209491,"eighty":54.057606,"marketCap":428373566715.29},{"date":"2025-07-25","current":54.897923,"twenty":50.594414,"median":52.555929,"eighty":55.711415,"marketCap":412107620053.2},{"date":"2025-08-01","current":59.731878,"twenty":50.855059,"median":52.994419,"eighty":55.972407,"marketCap":445624526286.47},{"date":"2025-08-08","current":59.478715,"twenty":51.107295,"median":53.05296,"eighty":56.541585,"marketCap":444845815775.64},{"date":"2025-08-15","current":61.917611,"twenty":51.356483,"median":53.519848,"eighty":59.478715,"marketCap":462392609292.46},{"date":"2025-08-22","current":58.782188,"twenty":51.569512,"median":54.477764,"eighty":60.15932,"marketCap":470428104569.66},{"date":"2025-08-29","current":59.85298,"twenty":51.666141,"median":55.691374,"eighty":59.937003,"marketCap":481284287403.35},{"date":"2025-09-05","current":65.582363,"twenty":51.677932,"median":55.770266,"eighty":60.732448,"marketCap":526832269752.24},{"date":"2025-09-12","current":62.481332,"twenty":51.8337,"median":55.972407,"eighty":61.285609,"marketCap":502824785657.99},{"date":"2025-09-19","current":63.179889,"twenty":52.120101,"median":56.254853,"eighty":61.852995,"marketCap":508085671393.42},{"date":"2025-09-26","current":63.528382,"twenty":52.146639,"median":56.965096,"eighty":62.270337,"marketCap":509562668601.01},{"date":"2025-10-03","current":64.989073,"twenty":52.165061,"median":57.272274,"eighty":62.504861,"marketCap":522523002865.02},{"date":"2025-10-10","current":61.782766,"twenty":52.193561,"median":59.039802,"eighty":62.657943,"marketCap":496019912951.91},{"date":"2025-10-17","current":58.903713,"twenty":52.323014,"median":59.170669,"eighty":62.619084,"marketCap":472537436949.31},{"date":"2025-10-24","current":59.187086,"twenty":52.484015,"median":59.039802,"eighty":62.52839,"marketCap":474983377696.11},{"date":"2025-10-31","current":57.072441,"twenty":52.552922,"median":59.021138,"eighty":62.417499,"marketCap":465758305542.93},{"date":"2025-11-07","current":54.713071,"twenty":52.619069,"median":58.881843,"eighty":62.304573,"marketCap":446224987036.64},{"date":"2025-11-14","current":55.883072,"twenty":52.812504,"median":58.231971,"eighty":62.27542,"marketCap":457058673340.29},{"date":"2025-11-21","current":52.805265,"twenty":52.880927,"median":57.030538,"eighty":62.209511,"marketCap":431684582485.14},{"date":"2025-11-28","current":55.237621,"twenty":52.99843,"median":56.630614,"eighty":62.069705,"marketCap":453209419829.34},{"date":"2025-12-05","current":54.841023,"twenty":53.00899,"median":56.437545,"eighty":61.965159,"marketCap":450729029423.46},{"date":"2025-12-12","current":56.212257,"twenty":53.045529,"median":56.385682,"eighty":61.891765,"marketCap":462853512587.19},{"date":"2025-12-19","current":54.083493,"twenty":53.045529,"median":56.227363,"eighty":61.831221,"marketCap":446374731108.34},{"date":"2025-12-24","current":54.414957,"twenty":53.090114,"median":56.103073,"eighty":61.798561,"marketCap":450509359276.9},{"date":"2026-01-02","current":53.078544,"twenty":53.065996,"median":55.972407,"eighty":61.785925,"marketCap":441174507319.22},{"date":"2026-01-09","current":56.743223,"twenty":53.0878,"median":56.0944,"eighty":61.695241,"marketCap":472808676524.34},{"date":"2026-01-16","current":55.187351,"twenty":53.304215,"median":56.103073,"eighty":61.405393,"marketCap":461338821289.95},{"date":"2026-01-23","current":52.546341,"twenty":53.0878,"median":56.076447,"eighty":61.296167,"marketCap":438839874056.97},{"date":"2026-01-30","current":51.677141,"twenty":52.994149,"median":55.908509,"eighty":61.278475,"marketCap":433553740508.2},{"date":"2026-02-06","current":50.918226,"twenty":52.680723,"median":55.839154,"eighty":61.101743,"marketCap":428270226283.58},{"date":"2026-02-13","current":51.771686,"twenty":52.512455,"median":55.711415,"eighty":60.890064,"marketCap":437949787160.49},{"date":"2026-02-20","current":51.752043,"twenty":52.351169,"median":55.691374,"eighty":60.824953,"marketCap":437153052005.04},{"date":"2026-02-27","current":50.215456,"twenty":52.151244,"median":55.507566,"eighty":60.720339,"marketCap":428825318404.97},{"date":"2026-03-06","current":49.335298,"twenty":51.80347,"median":55.280584,"eighty":60.654676,"marketCap":417912584744.19},{"date":"2026-03-13","current":48.90444,"twenty":51.75217,"median":55.201025,"eighty":60.572606,"marketCap":416170839186.33},{"date":"2026-03-20","current":48.948437,"twenty":51.671435,"median":55.086674,"eighty":60.515374,"marketCap":414967977646.95},{"date":"2026-03-27","current":47.483832,"twenty":51.400677,"median":54.94883,"eighty":60.443129,"marketCap":414588875872.42},{"date":"2026-04-02","current":49.302243,"twenty":51.107295,"median":54.905743,"eighty":60.227005,"marketCap":432534434303.11},{"date":"2026-04-10","current":49.055344,"twenty":50.995993,"median":54.897923,"eighty":60.186394,"marketCap":433687668394.36},{"date":"2026-04-17","current":48.417764,"twenty":50.589497,"median":54.65026,"eighty":60.143018,"marketCap":428230701835.75},{"date":"2026-04-24","current":45.835792,"twenty":50.342877,"median":54.475147,"eighty":60.015062,"marketCap":426879682872.04},{"date":"2026-04-30","current":44.026312,"twenty":50.285416,"median":54.355253,"eighty":59.903394,"marketCap":410132737659.64},{"date":"2026-05-08","current":43.161515,"twenty":50.207478,"median":54.262074,"eighty":59.804539,"marketCap":403472171949.3},{"date":"2026-05-15","current":44.128138,"twenty":49.985706,"median":54.115335,"eighty":59.70386,"marketCap":413593092820.6},{"date":"2026-05-22","current":41.244553,"twenty":49.583265,"median":53.983854,"eighty":59.631568,"marketCap":385683097978.4},{"date":"2026-05-29","current":40.98659,"twenty":49.34142,"median":53.840414,"eighty":59.564678,"marketCap":384603594259.51},{"date":"2026-06-05","current":38.394132,"twenty":49.063316,"median":53.633194,"eighty":59.459458,"marketCap":360799766229.36},{"date":"2026-06-12","current":39.515262,"twenty":48.81081,"median":53.517715,"eighty":59.36625,"marketCap":371084155232.86},{"date":"2026-06-18","current":39.444808,"twenty":48.417764,"median":53.467699,"eighty":59.301536,"marketCap":371311256576.18},{"date":"2026-06-26","current":39.60241,"twenty":47.951326,"median":53.090114,"eighty":59.187086,"marketCap":370974287810.31},{"date":"2026-07-03","current":44.319925,"twenty":47.638943,"median":53.015805,"eighty":59.069259,"marketCap":415476044901.86},{"date":"2026-07-10","current":45.319748,"twenty":47.348429,"median":52.993744,"eighty":59.024871,"marketCap":424327469311.14},{"date":"2026-07-17","current":43.189222,"twenty":46.151454,"median":52.805265,"eighty":58.96135,"marketCap":405818502739.33},{"date":"2026-07-24","current":43.433009,"twenty":45.632553,"median":52.604835,"eighty":58.912251,"marketCap":408200902707.63},{"date":"2026-07-31","current":43.935338,"twenty":45.29749,"median":52.543618,"eighty":58.877468,"marketCap":413706414238.87},{"date":"2026-08-07","current":44.394532,"twenty":45.008473,"median":52.339287,"eighty":58.813302,"marketCap":418841988303.56},{"date":"2026-08-14","current":42.6704,"twenty":44.628794,"median":52.189578,"eighty":58.452058,"marketCap":403085247281.44},{"date":"2026-08-21","current":40.686911,"twenty":44.408765,"median":52.120101,"eighty":57.75211,"marketCap":366558497066.13},{"date":"2026-08-28","current":40.334802,"twenty":44.24321,"median":51.814807,"eighty":57.336246,"marketCap":363468645736.13},{"date":"2026-09-04","current":39.220129,"twenty":44.050964,"median":51.771686,"eighty":57.152374,"marketCap":353565883607.49},{"date":"2026-09-11","current":36.382401,"twenty":43.912617,"median":51.717719,"eighty":57.022157,"marketCap":328426636361.34},{"date":"2026-09-16","current":37.134263,"twenty":43.825898,"median":51.677932,"eighty":56.983927,"marketCap":335564360039.49}],"updateTime":1789615250198},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"01276\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1149270469","title":"Hengrui Pharma to Close H-Share Register Ahead of 24 September 2026 Extraordinary Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=1149270469","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1149270469?lang=en_us&edition=fundamental","pubTime":"2026-09-07 19:03","pubTimestamp":1788778985,"startTime":"0","endTime":"0","summary":"Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Hengrui Pharma) will convene its first extraordinary shareholders’ meeting for 2026 at 2:30 p.m. on Thursday, 24 September 2026, in Pudong New Area,...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01276"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1187160052","title":"HENGRUI PHARMA Advances Pipeline with SHR-1179 Injection Clinical Trial Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=1187160052","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1187160052?lang=en_us&edition=fundamental","pubTime":"2026-09-07 18:52","pubTimestamp":1788778333,"startTime":"0","endTime":"0","summary":"Hengrui Pharma (01276) has announced that its subsidiary, Guangdong Hengrui Pharmaceutical Co., Ltd., has recently received the \"Drug Clinical Trial Approval Notice\" issued by the National Medical...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0405327494.USD","MDTX","LU1328615791.USD","LU2289578879.USD","BK0012","BMED","BK0060","LU2580892862.HKD","LU2580892789.USD","IBBQ","LU0359201885.HKD","LU0359201612.USD","LU2097828714.EUR","LU1064131003.USD","LU1255011170.USD","LU1781817850.SGD","BK0188","LU1064130708.USD","LU1146622755.USD","LU1580142542.USD","LU2543165471.USD","BK0028","LU1969619763.USD","600276","01276","BK0196","LU1655091616.SGD","LU0359202008.SGD","LU2097828631.EUR","PSYK","BK0183","LU1997245177.USD","LU2097828557.USD","LU2488822045.USD","LU1023057109.AUD","LU2097828474.EUR","LU2495084118.USD","BK0239","IBBJ","BK1191","LU1997245094.SGD","LU0405327148.USD","LU1820825898.SGD","LU2328871848.SGD","LU1997244956.HKD","LU2097828805.USD","LU2148510915.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665726313","title":"BlackRock's Long Position in H-Shares of Jiangsu Hengrui Pharmaceuticals Increases to 7.21% on SEP 2 from 5.92% - HKEX","url":"https://stock-news.laohu8.com/highlight/detail?id=2665726313","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665726313?lang=en_us&edition=fundamental","pubTime":"2026-09-07 17:47","pubTimestamp":1788774474,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260907:nFWN44W0Z9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0359201612.USD","LU1997244956.HKD","BK1191","LU1146622755.USD","LU2097828474.EUR","LU2495084118.USD","LU1064130708.USD","LU2097828714.EUR","BK0012","LU0405327494.USD","LU1064131003.USD","LU2328871848.SGD","LU2148510915.USD","LU2488822045.USD","LU1655091616.SGD","LU2097828631.EUR","BK0060","LU0405327148.USD","LU1781817850.SGD","LU2289578879.USD","LU1023057109.AUD","BK0196","LU2580892789.USD","LU2097828557.USD","LU1997245094.SGD","LU1997245177.USD","01276","LU0359202008.SGD","LU2543165471.USD","LU1820825898.SGD","LU1328615791.USD","600276","BK0239","LU2580892862.HKD","LU1580142542.USD","BK0028","LU2097828805.USD","LU1969619763.USD","BK0183","LU0359201885.HKD","LU1255011170.USD","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1110897642","title":"Hengrui Pharma Subsidiary Gains Clinical Trial Approval for Weight Management Drug Candidate","url":"https://stock-news.laohu8.com/highlight/detail?id=1110897642","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1110897642?lang=en_us&edition=fundamental","pubTime":"2026-09-07 17:22","pubTimestamp":1788772938,"startTime":"0","endTime":"0","summary":"Jiangsu Hengrui Pharmaceuticals Co., Ltd. (SH: 600276) has announced that its subsidiary, Shandong Shengdi Pharmaceutical Co., Ltd., recently received the Drug Clinical Trial Approval Notice issued...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2543165471.USD","BK0060","LU2580892789.USD","LU1328615791.USD","BK0239","LU0359202008.SGD","LU2289578879.USD","LU0405327494.USD","LU2097828631.EUR","LU1997245094.SGD","LU1781817850.SGD","LU2328871848.SGD","LU0359201612.USD","BK0012","LU1255011170.USD","LU2097828557.USD","IBBQ","LU1997245177.USD","LU2495084118.USD","LU1820825898.SGD","LU1655091616.SGD","LU1064130708.USD","BK1191","LU2097828474.EUR","LU2488822045.USD","LU1969619763.USD","LU2148510915.USD","BK0028","LU0405327148.USD","LU1023057109.AUD","LU0359201885.HKD","600276","BK0196","LU2097828805.USD","LU1997244956.HKD","LU1146622755.USD","01276","BK0188","BK0183","BMED","LU1064131003.USD","MDTX","IBBJ","PSYK","LU1580142542.USD","LU2097828714.EUR","LU2580892862.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1161797164","title":"August Buyback Report: 277 A-Share Firms Spend Over 13 Billion Yuan, More Than Half Beat the Shanghai Composite, Gaozheng Explosive Surges 68% in a Month","url":"https://stock-news.laohu8.com/highlight/detail?id=1161797164","media":"Deep News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1161797164?lang=en_us&edition=fundamental","pubTime":"2026-09-05 17:02","pubTimestamp":1788598952,"startTime":"0","endTime":"0","summary":"Data from Tonghuashun iFinD reveals that approximately 277 listed companies executed share buybacks in August, with combined monthly spending surpassing 13 billion yuan. Midea Group Co.,Ltd. (SZSE:...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["600227","LU0955669360.SGD","LU2097828631.EUR","IE00B031J352.USD","LU1675838814.USD","BK0012","BK0196","BK0028","LU0593848301.USD","LU0955648018.USD","LU0052750758.USD","LU1934453819.USD","LU1568876251.USD","IE0005HP3H50.USD","BK0077","LU0791591158.USD","BK0033","LU0823437842.USD","LU1993786604.SGD","002913","LU0072913022.USD","000333","LU2488822045.USD","LU0456842615.SGD","LU1064130708.USD","IE00B97KM107.HKD","LU2580892789.USD","BK0187","LU0405327148.USD","LU0955623706.USD","BK0188","IE00B8HQ1Z84.USD","LU1979443071.USD","LU1655091616.SGD","LU2097828557.USD","IE0032834883.USD","IE00B8L5B284.USD","LU0880133367.SGD","LU0067412154.USD","LU1997244956.HKD","IE00BPRC5H50.USD","LU0264606111.USD","BK0278","BK0066","LU1655091459.SGD","IE00B031HY20.USD","LU1226287529.USD","IE00B0JY6N72.USD","000001","IE00B031HW06.USD","LU0269904917.USD","LU0117844026.USD","LU2289578879.USD","LU1781817850.SGD","LU0396098781.USD","BK0175","LU0828238088.HKD","LU0320764599.SGD","LU0405327494.USD","IE00B5MMRT66.SGD","LU0231483743.USD","LU0831103253.SGD","BK0224","LU1048484197.HKD","LU1807302812.USD","LU2476274308.USD","LU2506952253.HKD","IE00B29SXG58.USD","IE0008368742.USD","LU0509642566.USD","BK0061","IE0009570106.USD","LU0890818403.SGD","LU2213484517.USD","LU1039395188.USD","LU0898667661.SGD","LU1366334651.USD","LU0572939691.SGD","LU2097828474.EUR","LU0862451753.SGD","IE00B067MR52.USD","LU0228659784.USD","IE00BZ08YR35.GBP","LU2495084118.USD","BK0056","IE0003851619.USD","LU0572940350.SGD","LU1328615791.USD","LU2328871848.SGD","00300","LU1130305938.SGD","BK0183","BK0239","IE00BZ08YT58.USD","LU2097828805.USD","600276","IE0031814852.USD","IE0003795394.USD","IE00B543WZ88.USD","002827","BK0214","LU1366334578.USD","BK0229","IE00BZ08YS42.EUR","IE0008368411.USD","LU0708995583.HKD","LU1146622755.USD","LU1997245094.SGD","LU1997245177.USD","LU2580892862.HKD","BK0026","BK0201","LU0862451837.USD","LU2148510915.USD","LU2778985437.USD","IE00BKZH1Z71.USD","LU0501845795.SGD","LU1255011170.USD","BK0070","LU0784639295.USD","LU1969619763.USD","LU0210527791.USD","LU1064131003.USD","01276","LU1568876335.HKD","LU1580142542.USD","BK0060","LU0791590937.USD","LU1820825898.SGD","LU2097828714.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1126407744","title":"Evaluating the Potential Value of Hengrui's HRS-9531 in an Intensifying GIP Competitive Landscape","url":"https://stock-news.laohu8.com/highlight/detail?id=1126407744","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1126407744?lang=en_us&edition=fundamental","pubTime":"2026-09-04 15:32","pubTimestamp":1788507126,"startTime":"0","endTime":"0","summary":"The valuation of innovative pharmaceutical companies is fundamentally anchored in the value of their pipeline assets. As a core candidate in Hengrui's metabolic disease franchise, the clinical...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0359201612.USD","LU1997244956.HKD","BK1191","LU1146622755.USD","LU2097828474.EUR","LU2495084118.USD","LU1064130708.USD","LU2097828714.EUR","BK0012","LU0405327494.USD","LU1064131003.USD","LU2328871848.SGD","LU2148510915.USD","LU2488822045.USD","LU1655091616.SGD","LU2097828631.EUR","BK0060","LU0405327148.USD","LU1781817850.SGD","LU2289578879.USD","LU1023057109.AUD","BK0196","LU2580892789.USD","LU2097828557.USD","LU1997245094.SGD","LU1997245177.USD","01276","LU0359202008.SGD","LU2543165471.USD","LU1820825898.SGD","LU1328615791.USD","600276","BK0239","LU2580892862.HKD","LU1580142542.USD","BK0028","LU2097828805.USD","LU1969619763.USD","BK0183","LU0359201885.HKD","LU1255011170.USD","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664138343","title":"Hengrui Pharmaceuticals Gets China Regulatory Acceptance for Atopic Dermatitis Drug Application","url":"https://stock-news.laohu8.com/highlight/detail?id=2664138343","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664138343?lang=en_us&edition=fundamental","pubTime":"2026-09-04 10:19","pubTimestamp":1788488392,"startTime":"0","endTime":"0","summary":"Jiangsu Hengrui Pharmaceuticals  unit Guangdong Hengrui Medicine obtained China's regulatory acceptance for the marketing authorization application of SHR-1819 injection.The drug is indicated for moderate-to-severe atopic dermatitis in adults, according to a Friday filing with the Shanghai bourse.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU2543165471.USD","01276","LU0359202008.SGD","LU1023057109.AUD","BK1191","LU0359201885.HKD","LU0359201612.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664818823","title":"Update: Hengrui Pharma Unit Secures China Nod For Diabetes Drug Application","url":"https://stock-news.laohu8.com/highlight/detail?id=2664818823","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664818823?lang=en_us&edition=fundamental","pubTime":"2026-09-03 10:24","pubTimestamp":1788402243,"startTime":"0","endTime":"0","summary":"Jiangsu Hengrui Pharmaceuticals  unit Shandong Shengdi received regulatory acceptance in China for the marketing application of its HRS-7535 tablets.The drug is indicated for blood sugar control in patients with type two diabetes mellitus, according to a Wednesday aftermarket filing with the Shanghai bourse.Shares of the company were up 1% in recent trade.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["01276","LU0359201885.HKD","BK1191","LU0359202008.SGD","LU2543165471.USD","LU1023057109.AUD","LU0359201612.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1125110251","title":"Hengrui Pharma's HRS-7535 Tablet Marketing Authorization Application Accepted by China's NMPA","url":"https://stock-news.laohu8.com/highlight/detail?id=1125110251","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1125110251?lang=en_us&edition=fundamental","pubTime":"2026-09-02 18:22","pubTimestamp":1788344549,"startTime":"0","endTime":"0","summary":"Jiangsu Hengrui Pharmaceuticals Co., Ltd. (HENGRUI PHARMA) has announced that its subsidiary, Shandong Shengdi Pharmaceutical Co., Ltd., recently received the \"Acceptance Notice\" from China's...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1328615791.USD","IPOS","BK0060","LU1255011170.USD","LU2495084118.USD","BK0028","LU0405327148.USD","LU0359201885.HKD","LU1820825898.SGD","LU1997244956.HKD","LU2097828474.EUR","LU2289578879.USD","LU1580142542.USD","600276","BK0239","LU1023057109.AUD","LU2097828631.EUR","LU0405327494.USD","LU1997245094.SGD","BK0012","BK1191","LU0359201612.USD","LU2580892862.HKD","BK0183","LU0359202008.SGD","LU1969619763.USD","LU1781817850.SGD","LU2148510915.USD","LU1064131003.USD","LU1655091616.SGD","LU1997245177.USD","BK0188","LU2580892789.USD","LU2097828805.USD","LU2097828714.EUR","01276","BK0196","LU2543165471.USD","LU2097828557.USD","LU2488822045.USD","LU1064130708.USD","LU1146622755.USD","LU2328871848.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1150175257","title":"Hengrui Pharma Has Not Yet Initiated Its A-Share Buyback Program as of End-August","url":"https://stock-news.laohu8.com/highlight/detail?id=1150175257","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1150175257?lang=en_us&edition=fundamental","pubTime":"2026-09-02 17:16","pubTimestamp":1788340577,"startTime":"0","endTime":"0","summary":"Hengrui Pharma (01276) has issued an announcement revealing that, as of August 31, 2026, the company has not yet started implementing its share repurchase plan.According to the disclosure, as of the...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["159982","BK0183","LU1655091616.SGD","600276","LU1820825898.SGD","LU2543165471.USD","03130","BK1147","LU2148510915.USD","02846","LU1023057109.AUD","BK0239","BK1191","LU2580892789.USD","LU2289578879.USD","BK0188","LU0359202008.SGD","LU1781817850.SGD","82846","BK0012","LU1064130708.USD","LU2097828474.EUR","LU2488822045.USD","LU1328615791.USD","LU1997245094.SGD","LU0405327148.USD","LU2097828631.EUR","LU2097828805.USD","LU1255011170.USD","LU1580142542.USD","LU1997245177.USD","BK0028","LU0359201885.HKD","03188","LU0405327494.USD","83188","LU1997244956.HKD","LU2328871848.SGD","LU1146622755.USD","83130","LU2097828714.EUR","LU2097828557.USD","399300","02827","LU0359201612.USD","LU2495084118.USD","BK0196","LU1969619763.USD","01276","BK0060","LU2580892862.HKD","07233","LU1064131003.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1170409073","title":"Jiangsu Hengrui's Subsidiary Receives Regulatory Nod for Diabetes Drug Application","url":"https://stock-news.laohu8.com/highlight/detail?id=1170409073","media":"Stock News","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1170409073?lang=en_us&edition=fundamental","pubTime":"2026-09-02 16:52","pubTimestamp":1788339152,"startTime":"0","endTime":"0","summary":"Jiangsu Hengrui Pharmaceuticals Co., Ltd. (SH: 600276) has announced that its subsidiary, Shandong Shengdi Pharmaceutical Co., Ltd., has received the Acceptance Notice from China's National Medical...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1064130708.USD","BK0028","LU1328615791.USD","BK0183","LU1997244956.HKD","LU0359201885.HKD","LU0405327494.USD","LU2328871848.SGD","LU0359202008.SGD","LU0359201612.USD","LU1255011170.USD","LU2289578879.USD","01276","IPOS","LU2495084118.USD","BK0012","BK0239","LU1580142542.USD","LU2488822045.USD","LU2097828805.USD","LU2580892789.USD","LU1064131003.USD","LU2097828474.EUR","LU2148510915.USD","LU2543165471.USD","BK0060","LU1146622755.USD","BK0188","LU2097828714.EUR","LU0405327148.USD","LU1997245094.SGD","600276","LU2580892862.HKD","LU1820825898.SGD","LU2097828557.USD","LU2097828631.EUR","LU1023057109.AUD","LU1781817850.SGD","LU1969619763.USD","LU1997245177.USD","BK1191","LU1655091616.SGD","BK0196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1100166191","title":"Movement Alert｜HENGRUI PHARMA Falls 3.05% in Regular Trading, Mid-Year Earnings Under Pressure Amid Broad Pharma Sector Weakness","url":"https://stock-news.laohu8.com/highlight/detail?id=1100166191","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1100166191?lang=en_us&edition=fundamental","pubTime":"2026-08-31 10:10","pubTimestamp":1788142223,"startTime":"0","endTime":"0","summary":"On August 31, HENGRUI PHARMA fell 3.05% in regular trading, trading at 46.56 HKD/share, with turnover of approximately 56.25 million HKD. The decline came as the broader pharmaceuticals sector...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Hengrui Pharma Falls as JPMorgan Boosts Short Position","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01276"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1133434643","title":"Hengrui Pharma's Interim Report Falls Flat: Legacy Blockbusters Fade as Revenue Posts First Half-Year Decline in Four Years","url":"https://stock-news.laohu8.com/highlight/detail?id=1133434643","media":"Deep News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1133434643?lang=en_us&edition=fundamental","pubTime":"2026-08-27 16:20","pubTimestamp":1787818843,"startTime":"0","endTime":"0","summary":"Jiangsu Hengrui Pharmaceuticals Co.,Ltd. (SSE: 600276) recently released its interim report for the first half of 2026, and the numbers paint a less-than-rosy picture. During the reporting period,...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0028","BK1191","LU0359201612.USD","BK0239","LU0359202008.SGD","600276","BK0012","LU1064130708.USD","LU1655091616.SGD","LU1969619763.USD","LU0405327148.USD","LU1997244956.HKD","LU2289578879.USD","LU1580142542.USD","LU0359201885.HKD","LU1023057109.AUD","LU1328615791.USD","LU1146622755.USD","LU2097828631.EUR","LU2495084118.USD","LU2543165471.USD","LU2580892789.USD","BK0188","01276","LU1064131003.USD","BK0183","LU1255011170.USD","LU2148510915.USD","LU2097828474.EUR","LU1997245177.USD","LU1997245094.SGD","LU2580892862.HKD","LU1820825898.SGD","BK0196","LU1781817850.SGD","LU2097828714.EUR","LU0405327494.USD","BK0060","LU2097828557.USD","LU2328871848.SGD","LU2097828805.USD","LU2488822045.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1165601808","title":"Movement Alert｜HENGRUI PHARMA Rises 3.04% in Regular Trading, GIC Private Limited Consecutively Increases Stake to 17.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=1165601808","media":"Market Focus","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1165601808?lang=en_us&edition=fundamental","pubTime":"2026-08-27 15:02","pubTimestamp":1787814123,"startTime":"0","endTime":"0","summary":"On August 27, HENGRUI PHARMA rose 3.04% in regular trading, trading at 48.12 HKD/share, with turnover of HKD 478 million.On the news front, Hong Kong Exchange disclosures revealed that Singapore...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"GIC Boosts Hengrui Pharma Stake to 17.19% as Shares Rise","news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01276"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1106227619","title":"Singapore Sovereign Fund Boosts Stake in Chinese Drugmaker with HK$185 Million Share Purchase","url":"https://stock-news.laohu8.com/highlight/detail?id=1106227619","media":"Deep News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1106227619?lang=en_us&edition=fundamental","pubTime":"2026-08-27 08:10","pubTimestamp":1787789429,"startTime":"0","endTime":"0","summary":"Hong Kong stock exchange disclosures have revealed a notable transaction involving a major global institutional investor and a leading Chinese pharmaceutical company.On August 21, GIC Private...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0405327494.USD","LU2580892789.USD","LU1997245177.USD","LU1146622755.USD","LU1580142542.USD","EWH","600276","BK0196","LU1997245094.SGD","LU2097828805.USD","LU1023057109.AUD","BK0239","LU1781817850.SGD","BK0060","LU2543165471.USD","BK0012","LU2097828474.EUR","LU1820825898.SGD","LU2580892862.HKD","LU0359201612.USD","LU1255011170.USD","LU2289578879.USD","BK0028","BK0183","LU0359201885.HKD","LU0405327148.USD","01276","BK4104","LU2328871848.SGD","LU1997244956.HKD","LU2495084118.USD","LU2488822045.USD","BK1191","LU1328615791.USD","LU2097828557.USD","LU1655091616.SGD","LU2148510915.USD","LU2097828631.EUR","LU1064130708.USD","GIC","LU2097828714.EUR","BK0188","LU0359202008.SGD","LU1969619763.USD","LU1064131003.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662790837","title":"JPMorgan Chase & Co.'S Short Position in H-Shares of Jiangsu Hengrui Pharmaceuticals Co., Ltd. Increases to 3.72% on August 21 from 2.57% - HKEX","url":"https://stock-news.laohu8.com/highlight/detail?id=2662790837","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662790837?lang=en_us&edition=fundamental","pubTime":"2026-08-26 18:28","pubTimestamp":1787740118,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nFWN44N0FH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2148510915.USD","LU2289578879.USD","LU0405327148.USD","LU2097828631.EUR","LU0359202008.SGD","LU1255011170.USD","LU2495084118.USD","BK0188","BK0060","LU1328615791.USD","LU1064131003.USD","BK1191","LU0359201885.HKD","LU1023057109.AUD","LU2097828557.USD","LU1580142542.USD","BK0183","LU2580892789.USD","LU1997244956.HKD","BK0012","LU2097828805.USD","LU1969619763.USD","BK0028","LU2488822045.USD","LU0359201612.USD","LU1997245177.USD","LU2543165471.USD","LU1146622755.USD","LU2097828714.EUR","LU0405327494.USD","LU1655091616.SGD","LU2580892862.HKD","LU2328871848.SGD","BK0196","LU1781817850.SGD","600276","01276","BK0239","LU1997245094.SGD","LU1064130708.USD","LU1820825898.SGD","LU2097828474.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1100671669","title":"Singapore's GIC Boosts Stake in Hengrui Pharma With HK$185 Million Share Purchase","url":"https://stock-news.laohu8.com/highlight/detail?id=1100671669","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1100671669?lang=en_us&edition=fundamental","pubTime":"2026-08-25 19:30","pubTimestamp":1787657435,"startTime":"0","endTime":"0","summary":"Hong Kong exchange filings reveal that on August 20, GIC Private Limited acquired an additional 3.6586 million shares of HENGRUI PHARMA (01276) at an average price of HK$50.5655 per share, bringing...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0359201612.USD","LU1997244956.HKD","BK1191","LU1146622755.USD","LU2097828474.EUR","LU2495084118.USD","LU1064130708.USD","LU2097828714.EUR","BK0012","LU0405327494.USD","LU1064131003.USD","LU2328871848.SGD","LU2148510915.USD","LU2488822045.USD","LU1655091616.SGD","LU2097828631.EUR","BK0060","LU0405327148.USD","LU1781817850.SGD","LU2289578879.USD","LU1023057109.AUD","BK0196","LU2580892789.USD","LU2097828557.USD","BK4104","LU1997245094.SGD","LU1997245177.USD","GIC","01276","LU0359202008.SGD","LU2543165471.USD","LU1820825898.SGD","LU1328615791.USD","600276","BK0239","LU2580892862.HKD","LU1580142542.USD","BK0028","LU2097828805.USD","LU1969619763.USD","BK0183","EWH","LU0359201885.HKD","LU1255011170.USD","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143746816","title":"HENGRUI PHARMA: GIC Private Limited Acquires Shares, Long Position Rises to 15.7%","url":"https://stock-news.laohu8.com/highlight/detail?id=1143746816","media":"HK Disclosure","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1143746816?lang=en_us&edition=fundamental","pubTime":"2026-08-25 17:16","pubTimestamp":1787649406,"startTime":"0","endTime":"0","summary":"GIC Private Limited bought 3.66 million shares of HENGRUI PHARMA at an average of HKD 50.5655 per share on August 20, 2026, involving about HKD 185.00 million.Prior to the acquisition, GIC Private...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01276"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662678835","title":"Chinese Drug Regulator Accepts Hengrui Pharma's Drug Marketing Application for HRG2010 Capsules","url":"https://stock-news.laohu8.com/highlight/detail?id=2662678835","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662678835?lang=en_us&edition=fundamental","pubTime":"2026-08-25 10:43","pubTimestamp":1787625833,"startTime":"0","endTime":"0","summary":"China's National Medical Products Administration accepted Jiangsu Hengrui Pharmaceuticals' (SHA:600276, HKG:1276) drug marketing authorization application for HRG2010 capsules, according to a Shanghai bourse filing on Tuesday.The drug is used for the treatment of Parkinson's disease.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1191","LU1023057109.AUD","LU0359201612.USD","LU0359202008.SGD","LU2543165471.USD","01276","LU0359201885.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1156894355","title":"HENGRUI PHARMA's HRG2010 Capsule Marketing Application Accepted by NMPA","url":"https://stock-news.laohu8.com/highlight/detail?id=1156894355","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1156894355?lang=en_us&edition=fundamental","pubTime":"2026-08-24 22:24","pubTimestamp":1787581455,"startTime":"0","endTime":"0","summary":"HENGRUI PHARMA (01276) has announced that its marketing authorization application for the HRG2010 capsule has been formally accepted by China's National Medical Products Administration (NMPA),...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1580142542.USD","LU1997245094.SGD","LU2097828805.USD","LU2580892789.USD","BK0239","BK0012","LU1997244956.HKD","BK1191","BK0060","LU2580892862.HKD","IPOS","LU1655091616.SGD","LU0405327148.USD","LU2289578879.USD","LU2097828714.EUR","LU1781817850.SGD","BK0028","LU2328871848.SGD","LU1255011170.USD","BK0188","LU1969619763.USD","LU1997245177.USD","600276","LU0359201612.USD","01276","LU0405327494.USD","LU2543165471.USD","LU1064130708.USD","LU2097828631.EUR","LU2097828474.EUR","LU0359201885.HKD","LU2097828557.USD","LU0359202008.SGD","LU1328615791.USD","LU2495084118.USD","LU1064131003.USD","BK0196","LU2488822045.USD","LU1146622755.USD","LU1023057109.AUD","LU1820825898.SGD","LU2148510915.USD","BK0183"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":2,"totalSize":200,"code":"91000000","status":"200"}]}}